0001209191-23-058377.txt : 20231212
0001209191-23-058377.hdr.sgml : 20231212
20231212185014
ACCESSION NUMBER: 0001209191-23-058377
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231211
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shukla Sanjay
CENTRAL INDEX KEY: 0001671026
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 231482493
MAIL ADDRESS:
STREET 1: C/O ATYR PHARMA, INC.
STREET 2: 10240 SORRENTO VALLEY ROAD, SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8587318389
MAIL ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-11
0
0001339970
aTYR PHARMA INC
LIFE
0001671026
Shukla Sanjay
10240 SORRENTO VALLEY ROAD
SUITE 300
SAN DIEGO
CA
92121
1
1
0
0
President and CEO
0
Common Stock
2023-12-11
4
P
0
3000
1.17
A
94173
D
Common Stock
2023-12-12
4
P
0
12000
1.178
A
106173
D
Represents weighted average price for the shares. The shares were purchased at prices ranging from $1.175 to $1.18 per share. The reporting
person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full
information regarding the number of shares purchased at each separate price.
/s/ Nancy E. Denyes, Attorney-in-Fact
2023-12-12